4 completed, 1 terminated. 5 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 4, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow Breastcancer: new trials by email Literature Review of Breastcancer trials Research Report on Breastcancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A PK Study of Oraxol in Breast Cancer Patients Oraxol - Breastcancer | Phase 1 | Completed | Athenex, Inc. | 24 | 2019-04-22 | 2021-08-06 |
| An Extension Study to Provide Oraxol to Patients Who Completed KX-ORAX-007 Oraxol - Breastcancer | Phase 1 | Terminated | Athenex, Inc. | 11 | 2017-10-25 | 2022-03-03 |
| A Clinical Study to Determine the Pharmacokinetics of Oraxol in Breast Cancer Patients Oraxol - Breastcancer | Phase 1 | Completed | Health Hope Pharma | 28 | 2017-05-09 | 2025-03-12 |
| SV-BR-1-GM in Metastatic or Locally Recurrent Breast Cancer SV-BR-1-GM, Cyclophosphamide, Interferon-alpha-2b - Breastcancer, Breast Neoplasm | Phase 1 / Phase 2 | Completed | BriaCell Therapeutics Corporation | 24 | 2017-05-05 | 2021-01-29 |
| Immunotherapy Vaccine and Herceptin in Breast Cancer GP2 peptide + GM-CSF vaccine plus trastuzumab, Trastuzumab - Breastcancer | Phase 1 | Completed | Cancer Insight, LLC | 30 | 2008-01-01 | 2017-01-09 |
Breast Neoplasms (3)
Breast Diseases (3) · Neoplasms (3) · Neoplasms by Site (3) · Skin Diseases (3) · Skin and Connective Tissue Diseases (3)
Cyclophosphamide (1) · Introns (1) · Paclitaxel (1) · Trastuzumab (1)
Athenex, Inc. (2) · BriaCell Therapeutics Corporation (1) · Cancer Insight, LLC (1) · Health Hope Pharma (1)
Taiwan (2) · China (1) · United States (1)
David Cutler, MD (1) · Erwei Song, Pro.f (1) · George E Peoples, MD (1) · George E Peoples, MD, FACS (1) · Herui Yao, Pro.f (1) · Tsu-Yi Chao, MD, DMS, PhD (1)